The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HVO HVIVO PLC ORD 5P



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  1.07 4.27 14.40 27.49 18.47
Operating Profit/(Loss)  -3.25 -1.15 -0.53 -1.41 -23.05
Net Interest  0.00 0.01 0.01 0.00 0.00
Profit Before Tax  -3.25 -1.16 -0.43 -1.19 -22.71
Profit After Tax  -2.77 -0.66 0.53 1.51 -18.44
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -2.77 -0.66 0.53 1.51 -18.44
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  -2.77 -0.66 0.53 1.51 -18.44
 
Continuing EPS
Earnings per Share - Basic  -6.75p -3.60p 1.50p 3.20p -31.30p
Earnings per Share - Diluted  -6.75p -3.60p 1.40p 2.90p -31.30p
Earnings per Share - Adjusted  -6.75p -3.60p 1.50p 3.20p -31.30p
Continuing and Discontinued EPS
Earnings per Share - Basic  -6.75p -3.60p 1.50p 3.20p -31.30p
Earnings per Share - Diluted  -6.75p -3.60p 1.40p 2.90p -31.30p
Earnings per Share - Adjusted  -6.75p -3.60p 1.50p 3.20p -31.30p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  0.28 0.40 1.38 3.67 3.15
Intangible Assets  0.00 0.00 0.00 1.08 5.06
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  0.28 0.40 1.38 4.75 8.21
Current Assets
Inventories  1.15 1.45 1.61 3.12 3.73
Trade & Other Receivables  1.76 3.39 3.77 8.28 6.71
Cash at Bank & in Hand  0.32 1.59 16.34 35.81 50.83
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  3.23 6.43 21.72 47.20 61.27
 
Total Assets  3.52 6.82 23.10 51.95 69.48
 
Liabilities
Current Liabilities
Borrowings  0.00 -0.37 0.00 0.00 0.00
Other Current Liabilities  -2.38 -4.82 -6.76 -8.36 -4.62
  -2.38 -5.19 -6.76 -8.36 -4.62
 
Net Current Assets  0.85 1.23 14.96 38.85 56.66
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  0.00 0.00 0.00 -0.11 -3.13
Other Non-Current Liabilities  0.00 0.00 0.00 -0.63 -0.55
  0.00 0.00 0.00 -0.74 -3.68
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -2.38 -5.19 -6.76 -9.09 -8.30
 
Net Assets  1.14 1.63 16.34 42.86 61.18
 
Capital & Reserves
Share Capital  2.34 1.10 2.05 2.69 3.38
Share Premium Account  1.80 0.00 13.01 37.36 72.50
Other Reserves  0.01 4.20 4.42 4.44 5.37
Retained Earnings  -3.01 -3.67 -3.14 -1.63 -20.07
Shareholders Funds  1.14 1.63 16.34 42.86 61.18
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  1.14 1.63 16.34 42.86 61.18

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  n/a n/a n/a n/a n/a
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a n/a n/a 113.33% n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  2.60p 23.15p 41.63p 57.32p 31.39p
Pre-Tax Profit per Share  -7.93p -6.31p -1.24p -2.49p -38.59p
Operating Margin  -304.59% -27.02% -3.66% -5.16% -124.85%
Return on Capital Employed  -286.08% -57.55% -2.55% -2.85% -38.31%
 
Continuing & Discontinued Operations
Dividend Yield  n/a n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  2.77p 3.97p 39.87p 77.76p 82.97p
Net Gearing  -28.46% -74.97% -100.01% -83.56% -83.08%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address Queen Mary BioEnterprises, Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom
Company website http://www.hvivo.com
Market cap(in millions)* £ 142.46
Listing/Admission to trading 03 May 2012
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
02-May-16
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 1,500
SEDOL B6ZM0X5
ISIN number GB00B6ZM0X53


Start trading your favourite asset CFDs!
Carries risk of capital loss



HVIVO share fundamentals (HVO)